This job has expired

Higher Scientific Officer - Cancer Biomarkers team

The Institute of Cancer Research
Sutton, London (Greater)
£32,000 - £44,400
Closing date
24 May 2022

View more

You need to sign in or create an account to save a job.

Key Information

Salary:  £32,000 - £44,400. Appointments are normally made at the starting salary, however comparable skills and experience will be considered. Future progression is based on annual performance review. 

Duration of Contract: 1 year in the first instance

Hours per week: 35 hours per week

Closing Date 24th May 2022

Job Details

Summary of Role

The main objective of this post is to play a major role in the expansion of the translational laboratories to support the preclinical and clinical development of novel anticancer drugs. Many of the agents under investigation will have been discovered in the Centre for Cancer Therapeutics.  Compounds approaching, and in, Phase 1 clinical trials will be investigated in collaboration with the Royal Marsden Hospital Drug Development Unit.  The aim of the work will be to identify, validate and apply immunohistochemical and immunofluorescence techniques to develop prognostics, diagnostic and pharmacodynamic markers of response in preclinical and clinical studies.

Key Requirements

Candidates must have significant experience in histopathology, and immunohistochemistry and immunofluorescence expertise, and should possess a first degree (or equivalent) in biomedical science, molecular biology/pharmacology or related subject, or will have an appropriate professional qualification (BMS/HCPC). An understanding of GCP would be an advantage.  

Department/Directorate Information

The Cancer Biomarkers team conducts biomarker-driven clinical and translational research to accelerate the development of novel cancer therapies and improve understanding of cancer biology, drug sensitivity and resistance. His team focuses on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA. His team consists of basic and clinical scientists, which is embedded in a vibrant world-class research environment.

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Ruth Riisnaes by emailing

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert